Table 2.

Recommendations and actions.

Recommendations	Actions
1. Promote SOGI data collection.	Choose a model for an inclusive collection of SOGI data.
	Advocate for a policy-change in data collection at your institution.
	Train all workforce interacting with patients on SOGI data collection.
2. Promote inclusion of transgender and gender diverse patients in cancer clinical trials.	Avoid presumptive language when drafting clinical protocols.
	Allow GAHT among concomitant medications, unless interactions with experimental drugs and/or procedures are scientifically documented.
	Do not exclude HIV + patients under treatment and with a clinically acceptable CD4 lymphocyte count to participate unless interactions between antiretroviral drugs and experimental drugs and/or procedures are scientifically documented.
3. Create safe and welcoming environments for transgender and gender diverse cancer patients.	Allow transgender and gender diverse patients to register with alias name and chosen gender to healthcare registries.
	Respect gender identity: use gender-sensitive language, ask for transgender and gender diverse patients' preferred pronouns.
	Avoid gender-labelled oncological services (e.g., female-only case studies in posters and/or other informative material in waiting rooms and clinics for gynecological cancers care).
	In the case of in-patient clinics offering shared rooms, transgender and gender diverse patients should be assigned to shared rooms based on their gender preference.
	Implement gender-neutral restrooms.
	Display symbols such as rainbow flag or transgender flag on official websites of hospitals.
4. Improve cancer screening guidelines referred to transgender and gender diverse individuals.	Counsel and refer patients for oncological screening programs based on their anatomy and actual risk factors, not based on sex assigned at birth alone.
5. Provide education and training to oncology HCPs about transgender and gender diverse people’s health issues.	Promote education on gender-sensitive healthcare and approaches.
	Organize didactic events on T transgender and gender diverse people’s health topics at your institution.
6. Provide information to transgender and gender diverse people, especially youth, about modifiable cancer risk factors and other risk-increasing conditions.	Promote awareness campaigns targeted towards young LGBTQIA + individuals about quitting smoking, reducing alcohol consumption, the importance of physical activity, and healthy nutrition, and prevention and screening for sexually transmitted infections.
	Promote the use of pre-exposure prophylaxis (PrEP) prior to engaging in high-risk sexual activities.
	Promote HBV and HPV vaccinations.
7. Coordinate gender affirming care and cancer care on a case-by-case basis.	Consider a close collaboration with endocrinologists, surgeons, psychologists, and other relevant health professionals before outlining a treatment strategy.
	Do not interrupt GAHT unless strictly clinically needed or as requested by patients.
	Always share treatment decisions with your patients.
8. Provide psychological support during the whole cancer care continuum.	Collaborate with the psychological service of your health center since the patient’s initial assessment.
	Screen, identify early and manage possible signs of exacerbation or occurrence of gender dysphoria during the cancer care continuum.
	Inquire about the support network of transgender and gender diverse patients to foster local collaborations.
9. Address social determinants of health.	Work to minimize financial barriers by connecting patients with available resources such as local support organizations.
	Implement culturally, appropriate, and acceptable communication.
	Advocate for a real empowerment of transgender community: offer guidance to transgender and gender diverse patients on how they can assert their rights to receive a proper care.
10. Collaborate with LGBTQIA + organizations.	Contact representatives of LGBQTIA + organizations in your area and collaborate with them for new research projects.
	Make sure that transgender community’s voices are always heard and incorporated within the research and care process.